Streetbeat News

Stock Prices

TSLA

GLJ Research analyst Gordon Johnson warns that Tesla's valuation could collapse as competition intensifies, comparing it to the fate of Blackberry. Johnson has a Sell rating on the stock and a $24.33 price target. He notes that Tesla's recent stock surge has come despite bad news and may be due to the Treasury's liquidity injection into equity markets.

Portfolio Pulse from Shanthi Rexaline

June 01, 2023 | 12:22 pm

IEF

MDT

MRK

WMB

CNBC's 'Halftime Report Final Trades' featured recommendations from financial experts, including iShares 7-10 Year Treasury Bond ETF (IEF), Medtronic (MDT), Merck (MRK), and Williams Companies (WMB). Medtronic recently issued weak guidance and announced the acquisition of EOFlow, while Merck announced positive data from a Phase 3 trial for advanced renal cell carcinoma treatment. Williams Companies posted better-than-expected Q1 results.

Portfolio Pulse from Priya Nigam

June 01, 2023 | 12:21 pm

BILI

Bilibili Inc reported Q1 FY23 revenue growth of 0.3% YoY to $738.2 million, beating consensus estimates. MAUs reached 315.2 million, and DAUs climbed 18% YoY. However, mobile game revenues fell 17% YoY, and shares traded lower by 1.66% in the premarket session.

Portfolio Pulse from Anusuya Lahiri

June 01, 2023 | 12:20 pm

LXRX

Lexicon Pharmaceuticals announced the pricing of its $125M public offering of 23,924,705 shares at $2.60 per share and a concurrent private placement. The company plans to use the proceeds to fund the commercial launch of INPEFA and continued R&D of its drug candidates.

Portfolio Pulse from Happy Mohamed

June 01, 2023 | 12:18 pm

SPY

ADP reported a nonfarm employment change of 278K in May, significantly higher than the estimated 170K.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:17 pm

CROX

EA

NVDA

Insiders have sold shares in Nvidia, Electronic Arts, and Crocs, potentially indicating concerns about the companies' prospects or overpriced stocks. This follows recent financial reports and price target adjustments for the respective companies.

Portfolio Pulse from Lisa Levin

June 01, 2023 | 12:14 pm

REUN

Reunion Neuroscience shares have resumed trading after a temporary halt.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:12 pm

M

Macy's CEO reported that demand worsened across nameplates as April progressed, indicating a potential negative impact on the company's performance.

Portfolio Pulse from Charles Gross

June 01, 2023 | 12:12 pm

CTAS

Over the past 3 months, 8 analysts have published their opinion on Cintas (NASDAQ:CTAS) stock, with an average 12-month price target of $510.12. The average price target has increased by 5.94% over the past month.

Portfolio Pulse from Benzinga Insights

June 01, 2023 | 12:12 pm

HZNP

Horizon Therapeutics (NASDAQ:HZNP) announced new data from the Phase 3 N-MOmentum pivotal trial of UPLIZNA, which shows the drug's efficacy in reducing biomarker levels associated with Neuromyelitis Optica Spectrum Disorder (NMOSD) attacks and disability worsening. The results were published in The Journal of Neurology, Neurosurgery and Psychiatry.

Portfolio Pulse from Happy Mohamed

June 01, 2023 | 12:10 pm